EX-99.1 2 ex_922748.htm EXHIBIT 99.1 ex_922748.htm

Exhibit 99.1

 

LightPath Technologies Reports Fiscal 2026 Third Quarter Financial Results

 

ORLANDO, FL  May 7, 2026 – LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal third quarter ended March 31, 2026.

 

Financial Summary:

 

   

Three Months Ended March 31,

 

$ in millions

 

2026

   

2025

   

% Change

 

Revenue

  $ 19.1     $ 9.2       109 %

Gross Profit

  $ 7.0     $ 2.7       161 %

Operating Expenses*

  $ 11.2     $ 6.1       83 %

Net Loss

  $ (4.1 )   $ (3.6 )     15 %

Adjusted EBITDA** (non-GAAP)

  $ 1.1     $ (1.6 )     170 %

 

*Inclusive of $3.4 million and $0.1 million, respectively, for change in fair value of acquisition earnout liabilities.

**Reconciliation of this non-GAAP financial measure is provided below.

 

Third Quarter Fiscal 2026 & Subsequent Highlights:

 

 

Ended the third quarter of fiscal 2026 with a record order backlog of approximately $110.6 million, an increase of 196% from $37.4 million as of June 30, 2025, reflecting growing customer demand for infrared cameras, assemblies, and BlackDiamond™ based optical solutions.

 

 

Acquired the assets of Amorphous Materials, Inc. (“AM”) in January 2026, an industrial manufacturer with complementary Chalcogenide glass melting technologies for large diameter optics, adding a second U.S. manufacturing location for BlackDiamond™ glass.

 

 

Hosted an Investor Day in February 2026, during which management outlined the Company’s updated three pillar growth strategy targeting in excess of $300 million in annual revenue within five years, anchored by assemblies, infrared camera systems, and large defense programs.

 

 

Appointed Doug Schoen as Senior Vice President of Global Sales and Ryan Workman as Vice President, Business Development & Product Management in April 2026, adding more than 40 combined years of defense, aerospace, and Electro-Optical/Infrared business development experience to accelerate conversion of pipeline into contracted revenue.

 

Management Commentary

 

Sam Rubin, President and Chief Executive Officer of LightPath, said: “The third quarter of fiscal 2026 demonstrated continued execution against our vertically integrated strategy, with revenue growing 109% year over year to $19.1 million and gross profit expanding 161% year over year to $7.0 million. We delivered our third consecutive quarter of positive adjusted EBITDA and ended the quarter with a record order backlog of $110.6 million, up 196% from the start of the fiscal year. The scale and quality of our backlog is the clearest indication yet that LightPath has established itself as a mission critical supplier for some of the most important optical and infrared imaging programs in the U.S. and allied defense industrial base.

 

 

 

“The strategic thesis we have been executing against for the past several years continues to be reinforced by customer behavior and U.S. government policy. The Fiscal Year 2026 National Defense Authorization Act directs the U.S. Department of War to eliminate reliance on optical glass and optical systems sourced from certain foreign nations by January 1, 2030. Our broad offering of BlackDiamond™ chalcogenide glasses, including those licensed exclusively from the U.S. Naval Research Laboratory, along with our infrared cameras, assemblies, and thermal imaging systems, are already designed, manufactured, and delivered in alignment with those requirements. With the addition of AM, we now operate two U.S. based BlackDiamond™ glass production sites and have expanded our infrared glass portfolio to roughly 20 proprietary compositions, which is among the broadest selection of infrared materials available anywhere.

 

“Our February Investor Day laid out where we go from here. We are organizing the business around three pillars of growth: optical assemblies, infrared camera systems, and large defense programs of record. Each pillar has an addressable market measured in hundreds of millions to billions of dollars, and each is enabled by the same underlying BlackDiamond™, molding, coating, and camera technologies. Programs such as NGSRI, SPEIR, Apache, border surveillance, and counter UAS are no longer theoretical; they are in production or nearing it, and they increasingly carry BlackDiamond™ content. We are on track to complete the redesign of G5’s cooled infrared camera family onto BlackDiamond™ by the end of summer 2026, and beleive that this will position LightPath to meet long range camera demand at scale while competitors continue to work through the Germanium supply constraint.

 

“With a strong balance sheet, two operating glass manufacturing facilities, an expanded camera portfolio, and a deeper senior commercial leadership team following the appointments of Doug Schoen and Ryan Workman, we believe LightPath is well positioned to continue converting our record backlog into revenue, expand margins as volume scales, and pursue further accretive M&A that accelerates our transition into a platform provider of mission critical optical and imaging solutions,” concluded Rubin.

 

Third Quarter Fiscal 2026 Financial Results

 

Revenue for the third quarter of fiscal 2026 increased 109% to $19.1 million, as compared to $9.2 million in the same quarter of the prior fiscal year. Revenue was split amongst the Company’s product groups in the third quarter of fiscal 2026 and the same quarter of the prior fiscal year as follows:

 

Product Group Revenue ($ in millions)***

 

Third Quarter of Fiscal 2026

   

Third Quarter of Fiscal 2025

   

% Change

 

Infrared ("IR") Components

  $ 6.1     $ 3.6      

69%

 

Visible Components

  $ 4.0     $ 2.8      

40%

 

Assemblies & Modules

  $ 8.4     $ 1.9      

355%

 

Engineering Services

  $ 0.6     $ 0.8      

(29)%

 

 

*** Numbers may not foot due to rounding

 

Gross profit increased 161.1% to $7.0 million, or 36% of total revenues, in the third quarter of fiscal 2026, as compared to $2.7 million, or 29% of total revenues, in the same year-ago quarter. The increase in gross margin as a percentage of revenue was primarily driven by the increase in revenue from assemblies and modules, which generally carry higher margins, as well as an improved infrared component mix and manufacturing yields.

 

 

 

Operating expenses for the third quarter of fiscal 2026 include a fair value adjustment of $3.4 million related to the G5 earnout liability, which will continue to be adjusted through operating expenses until it is fully paid out. Excluding this amount, operating expenses increased $1.8 million, or 30%, to $7.8 million for the third quarter of fiscal 2026, as compared to $6.0 million in the same year-ago quarter. The increase was primarily driven by integration of G5 Infrared and AM, increased sales and marketing spend, higher information technology spend to meet customer security requirements, and increased SG&A personnel costs.

 

Net loss in the third quarter of fiscal 2026 totaled $4.1 million, or $0.07 per basic and diluted share, as compared to $3.6 million, or $0.44 per basic and diluted share, in the same year-ago quarter. The year-over-year change in net loss was primarily attributable to the change in fair value of acquisition liabilities for the earnout related to the acquisition of G5 Infrared.

 

Adjusted EBITDA** for the third quarter of fiscal 2026 was $1.1 million, as compared to an adjusted EBITDA loss of $1.6 million for the same year-ago quarter. The increase was primarily attributable to the increase in gross profit, driven by higher sales, partially offset by increased SG&A and new product development costs.

 

Cash and cash equivalents as of March 31, 2026 totaled $55.2 million, as compared to $4.9 million as of June 30, 2025. Total backlog as of March 31, 2026 was approximately $110.6 million, an increase of 196% compared to $37.4 million as of June 30, 2025.

 

Third Quarter Fiscal 2026 Earnings Call

 

Management will host an investor conference call at 5:00 p.m. Eastern time today, Thursday, May 7, 2026, to discuss the Company's third quarter fiscal 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

 

Q3 FY2026 Earnings Conference Call
Date: Thursday, May 7, 2026

Time: 5:00 p.m. Eastern time

U.S. Dial-in: 1-833-316-1983

International Dial-in: 1-785-838-9310

Conference ID: LIGHT

Webcast: LPTH Q3 FY2026 Earnings Conference Call

 

Please join at least five minutes before the start of the call to ensure timely participation.

 

A playback of the call will be available through Thursday, May 21, 2026. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 11161627. A webcast replay will also be available using the webcast link above.

 

About LightPath Technologies

 

LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath's family of custom solutions range from proprietary BlackDiamond™ chalcogenide-based glass materials – sold under exclusive license from the U.S. Naval Research Laboratory – to complete infrared optical systems and thermal imaging assemblies. The Company's primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, New Hampshire, Latvia and China. To learn more, please visit www.lightpath.com.

 

 

 

**Use of Non-GAAP Financial Measures

 

To provide investors with additional information regarding financial results, this press release includes references to EBITDA and adjusted EBITDA, which are non-GAAP financial measures. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization. We also calculate adjusted EBITDA, which excludes, as applicable: (1) stock compensation expenses; (2) the loss on extinguishment of debt; (3) the effect of the non-cash income or expense associated with the mark-to-market adjustments, related to the warrants; (4) the effect of non-cash income or expenses associated with the fair value adjustments related to the acquisition earnout liabilities; (5) acquisition costs, including legal fees and due diligence; and (6) the effect of foreign exchange gains or losses.

 

A "non-GAAP financial measure" is generally defined as a numerical measure of a company's historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company's management believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that these non-GAAP financial measures enhance the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.

 

LIGHTPATH TECHNOLOGIES, INC.
Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure

 

   

(unaudited)

       
   

Three Months Ended

   

Nine Months Ended

 
   

March 31,

   

March 31,

 
   

2026

   

2025

   

2026

   

2025

 

Net loss

  $ (4,106,287 )   $ (3,582,460 )   $ (16,404,698 )   $ (7,817,202 )

Depreciation and amortization

    1,263,005       1,463,150       3,717,691       3,356,752  

Income tax provision

    91,390       100,031       203,216       160,192  

Interest (income) expense

    (271,641 )     486,833       282,235       805,246  

EBITDA

  $ (3,023,533 )   $ (1,532,446 )   $ (12,201,556 )   $ (3,495,012 )

Stock-based compensation

    562,966       239,134       1,261,577       745,155  

Loss on extinguishment of debt

          418,502       506,280       418,502  

Change in fair value of warrant liability

          (870,554 )           (870,554 )

Change in fair value of acquisition earnout liabilities

    3,393,000       130,445       12,234,529       130,445  

Acquisition costs

    145,539             220,175        

Foreign exchange loss (gain)

    59,195       (7,627 )     115,264       (11,701 )

Adjusted EBITDA

  $ 1,137,167     $ (1,622,546 )   $ 2,136,269     $ (3,083,165 )

% of revenue

    6 %     -18 %     4 %     -12 %

 

 

 

Forward-Looking Statements

 

This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "guidance," "plan," "estimate," "will," "would," "project," "maintain," "intend," "expect," "anticipate," "prospect," "strategy," "future," "likely," "may," "should," "believe," "continue," "opportunity," "potential," and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding expectations, beliefs, hopes, intentions or strategies regarding, among other things, the Company’s ability to execute on its growth strategy to deliver revenue growth and value to its shareholders; the Company’s belief that it has established itself as a mission critical supplier for programs in the U.S. and allied defense industrial base; the Company’s expectations regarding customer behavior and U.S. government policy; the Company’s expectations regarding its timing of the redesign of G5’s infrared products; the Company’s ability to grow its backlog, expand margins as volume scales and pursue acquisitions, as well as other statements that are other than historical fact. These forward-looking statements are based on information available at the time the statements are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the likelihood that the impact of varying demand for the Company products; the U.S. government's initiatives to move away from using optical systems from certain foreign nations; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; the Company's reliance on a few key customers; the ability of the Company to obtain needed raw materials and components from its suppliers; the impact that international tariffs may have on our business and results of operations; the impact of political and other risks as a result of our sales to internal customers and/or our sourcing of materials from international suppliers; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; geopolitical tensions, the Russian-Ukraine conflict, and the Hamas-Israel war; the effects of steps that the Company could take to reduce operating costs; and those factors detailed by the Company in its public filings with the Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

 

Investor Relations Contact

Lucas A. Zimmerman

Managing Director

MZ Group – MZ North America

LPTH@mzgroup.us

+1 (949) 259-4987

 

 

 

 

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Balance Sheets

(unaudited)

 

   

March 31,

   

June 30,

 
   

2026

   

2025

 

Assets

               

Current assets:

               

Cash and cash equivalents

  $ 55,235,181     $ 4,877,036  

Trade accounts receivable, net of allowance of $49,017 and $24,495

    10,797,645       9,455,310  

Inventories, net

    13,344,705       12,858,838  

Prepaid expenses and deposits

    3,440,598       1,142,661  

Other current assets

    185,503       40,150  

Total current assets

    83,003,632       28,373,995  
                 

Property and equipment, net

    15,828,239       15,864,061  

Operating lease right-of-use assets

    8,406,283       7,429,378  

Intangible assets, net

    17,589,628       15,987,923  

Goodwill

    19,315,177       13,753,921  

Deferred tax assets, net

    22,233       22,571  

Other assets

    99,987       73,917  

Total assets

  $ 144,265,179     $ 81,505,766  

Liabilities and Stockholders’ Equity

               

Current liabilities:

               

Accounts payable

  $ 6,030,975     $ 7,421,430  

Accrued liabilities

    10,813,017       5,686,396  

Accrued payroll and benefits

    3,125,747       2,359,152  

Operating lease liabilities, current

    1,177,423       1,254,062  

Loans payable, current portion

    113,085       172,567  

Finance lease obligation, current portion

    271,015       206,518  

Total current liabilities

    21,531,262       17,100,125  

Deferred tax liabilities, net

    88,099       152,760  

Accrued liabilities, noncurrent

          823,000  

Finance lease obligation, less current portion

    460,316       421,363  

Operating lease liabilities, noncurrent

    9,197,980       8,326,250  

Loans payable, less current portion

    103,661       4,804,990  

Total liabilities

    31,381,318       31,628,488  
                 

Commitments and Contingencies

               
                 

Series G Convertible Preferred Stock; $0.01 par value; 44,000 shares authorized; 17,346 and 24,956 shares issued and outstanding

  $ 23,794,184     $ 34,232,510  
                 

Stockholders’ equity:

               

Preferred stock: Series D, $0.01 par value, voting; 500,000 shares authorized; none issued and outstanding

           

Common stock: Class A, $0.01 par value, voting; 94,500,000 shares authorized; 61,207,012 and 42,949,307 shares issued and outstanding

    612,070       429,493  

Additional paid-in capital

    334,313,395       244,953,346  

Accumulated other comprehensive income

    1,285,667       978,686  

Accumulated deficit

    (247,121,455 )     (230,716,757 )

Total stockholders’ equity

    89,089,677       15,644,768  

Total liabilities, convertible preferred stock and stockholders’ equity

  $ 144,265,179     $ 81,505,766  

 

 

 

 

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(unaudited)

 

   

Three Months Ended

   

Nine Months Ended

 
   

March 31,

   

March 31,

 
   

2026

   

2025

   

2026

   

2025

 

Revenue, net

  $ 19,149,814     $ 9,167,627     $ 50,559,747     $ 24,992,837  

Cost of sales

    12,193,531       6,503,526       33,100,562       17,553,476  

Gross profit

    6,956,283       2,664,101       17,459,185       7,439,361  

Operating expenses:

                               

Selling, general and administrative

    6,296,286       4,448,359       16,539,617       11,075,005  

New product development

    1,041,794       757,938       2,658,051       1,998,775  

Amortization of intangible assets

    477,245       779,025       1,378,295       1,469,512  

Change in fair value of acquisition earnout liabilities

    3,393,000       130,445       12,234,529       130,445  

Loss on disposal of property and equipment

          2,068       4,016       80,505  

Total operating expenses

    11,208,325       6,117,835       32,814,508       14,754,242  

Operating loss

    (4,252,042 )     (3,453,734 )     (15,355,323 )     (7,314,881 )

Other income (expense):

                               

Interest income (expense), net

    271,641       (486,833 )     (282,235 )     (805,246 )

Loss on extinguishment of debt

          (418,502 )     (506,280 )     (418,502 )

Change in fair value of warrant liability

          870,554             870,554  

Other expense (income), net

    (34,496 )     6,086       (57,644 )     11,065  

Total other income (expense)

    237,145       (28,695 )     (846,159 )     (342,129 )

Loss before income taxes

    (4,014,897 )     (3,482,429 )     (16,201,482 )     (7,657,010 )

Income tax provision

    91,390       100,031       203,216       160,192  

Net loss

  $ (4,106,287 )   $ (3,582,460 )   $ (16,404,698 )   $ (7,817,202 )

Foreign currency translation adjustment

    1,739       120,572       306,981       (58,869 )

Comprehensive loss

  $ (4,104,548 )   $ (3,461,888 )   $ (16,097,717 )   $ (7,876,071 )

Loss per common share (basic)

  $ (0.07 )   $ (0.09 )   $ (0.33 )   $ (0.19 )

Number of shares used in per share calculation (basic)

    58,628,741       41,363,643       49,572,872       40,209,657  

Loss per common share (diluted)

  $ (0.07 )   $ (0.09 )   $ (0.33 )   $ (0.19 )

Number of shares used in per share calculation (diluted)

    58,628,741       41,363,643       49,572,872       40,209,657  

 

 

 

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Changes in Stockholders' Equity

(unaudited)

 

   

Temporary Equity

                           

Accumulated

                 
   

Series G Convertible

   

Class A

   

Additional

   

Other

           

Total

 
   

Preferred Stock

   

Common Stock

   

Paid-in

   

Comprehensive

   

Accumulated

   

Stockholders’

 
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Income

   

Deficit

   

Equity

 

Balances at June 30, 2025

    24,956     $ 34,232,510       42,949,307     $ 429,493     $ 244,953,346     $ 978,686     $ (230,716,757 )   $ 15,644,768  

Issuance of common stock for:

                                                               

Exercise of stock options, RSUs & RSAs, net

                8,583       86       (86 )                  

Issuance of common stock under private equity placement

                1,600,000       16,000       7,878,045                   7,894,045  

Issuance of common stock for acquisition of Visimid

                112,323       1,123       348,877                   350,000  

Stock-based compensation on stock options, RSUs & RSAs

                            349,624                   349,624  

Foreign currency translation adjustment

                                  92,383             92,383  

Net loss

                                        (2,893,002 )     (2,893,002 )

Balances at September 30, 2025

    24,956     $ 34,232,510       44,670,213     $ 446,702     $ 253,529,806     $ 1,071,069     $ (233,609,759 )   $ 21,437,818  

Issuance of common stock for:

                                                               

Exercise of stock options, RSUs & RSAs, net

                120,234       1,203       (1,203 )                  

Exercise of warrants

                739,730       7,397       (7,397 )                  

Issuance of common stock under public equity placement

                8,912,500       89,125       65,251,709                   65,340,834  

Stock-based compensation on stock options, RSUs & RSAs

                            348,986                   348,986  

Foreign currency translation adjustment

                                  212,859             212,859  

Net loss

                                        (9,405,409 )     (9,405,409 )

Balances at December 31, 2025

    24,956     $ 34,232,510       54,442,677     $ 544,427     $ 319,121,901     $ 1,283,928     $ (243,015,168 )   $ 77,935,088  

Issuance of common stock for:

                                                               

Employee Stock Purchase Plan

                2,302       23       24,839                   24,862  

Exercise of stock options, RSUs & RSAs, net

                112,723       1,127       11,376                   12,503  

Exercise of warrants

                2,728,968       27,290       (27,290 )                  

Fees for issuance of common stock under public equity placement

                            (98,293 )                 (98,293 )

Issuance of common stock for acquisition of Amorphous

                83,518       835       1,026,245                   1,027,080  

Issuance of common stock for acquisition of G5

                297,445       2,974       3,146,968                   3,149,942  

Conversion of Series G Preferred to Common

    (7,610 )     (10,438,326 )     3,539,379       35,394       10,402,932                   10,438,326  

Stock-based compensation on stock options, RSUs & RSAs

                            704,717                   704,717  

Foreign currency translation adjustment

                                  1,739             1,739  

Net loss

                                        (4,106,287 )     (4,106,287 )

Balances at March 31, 2026

    17,346     $ 23,794,184       61,207,012     $ 612,070     $ 334,313,395     $ 1,285,667     $ (247,121,455 )   $ 89,089,677  
                                                                 

Balances at June 30, 2024

        $       39,254,643     $ 392,546     $ 245,140,758     $ 509,936     $ (215,843,575 )   $ 30,199,665  

Issuance of common stock for:

                                                               

Employee Stock Purchase Plan

                8,232       82       10,290                   10,372  

Exercise of Stock Options, RSUs & RSAs, net

                70,309       703       (703 )                  

Issuance of common stock for acquisition of Visimid

                279,553       2,796       318,562                   321,358  

Stock-based compensation on stock options, RSUs & RSAs

                            264,475                   264,475  

Foreign currency translation adjustment

                                  271,594             271,594  

Net loss

                                        (1,622,745 )     (1,622,745 )

Balances at September 30, 2024

        $       39,612,737     $ 396,127     $ 245,733,382     $ 781,530     $ (217,466,320 )   $ 29,444,719  

Issuance of common stock for:

                                                               

Exercise of Stock Options, RSUs & RSAs, net

                229,097       2,291       (2,291 )                  

Shares issued as compensation

                49,000       490       89,180                   89,670  

Stock-based compensation on stock options, RSUs & RSAs

                            231,581                   231,581  

Foreign currency translation adjustment

                                  (451,035 )           (451,035 )

Net loss

                                        (2,611,997 )     (2,611,997 )

Balances at December 31, 2024

        $       39,890,834     $ 398,908     $ 246,051,852     $ 330,495     $ (220,078,317 )   $ 26,702,938  

Issuance of preferred stock under private equity placement, net of fees

    24,956       19,648,488                                      

Issuance of common stock for:

                                                               

Employee Stock Purchase Plan

                1,137       11       4,002                   4,013  

Exercise of Stock Options, RSUs & RSAs, net

                238,641       2,387       788                   3,175  

Issuance of common stock for acquisition of Visimid

                102,700       1,027       391,561                   392,588  

Issuance of common stock for acquisition of G5

                1,972,501       19,725       4,852,343                   4,872,068  

Issuance of common stock under private equity placement, net of fees

                687,750       6,878       1,584,014                   1,590,892  

Issuance of warrants under private placement, net of fees

                            177,445                   177,445  

Preferred cumulative dividends plus accretion

          14,751,134                   (14,751,134 )                 (14,751,134 )

Stock-based compensation on stock options, RSUs & RSAs

                            194,303                   194,303  

Foreign currency translation adjustment

                                  120,572             120,572  

Net loss

                                        (3,582,460 )     (3,582,460 )

Balances at March 31, 2025

    24,956     $ 34,399,622       42,893,563     $ 428,936     $ 238,505,174     $ 451,067     $ (223,660,777 )   $ 15,724,400  

 

 

 

 

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Cash Flows

(unaudited)

 

   

Nine Months Ended

 
   

March 31,

 
   

2026

   

2025

 

Cash flows from operating activities:

               

Net loss

  $ (16,404,698 )   $ (7,817,202 )

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    3,717,691       3,356,752  

Interest from amortization of loan issuance costs

    90,124       161,905  

Amortization of fair value of loan

    90,321        

Loss on extinguishment of debt

    506,280       418,502  

Change in fair value of warrant liability

          (870,554 )

Change in fair value of acquisition earnout liabilities

    12,234,529       130,445  

Earnout payment for acquisition of G5, net of financing portion

    (3,813,587 )      

Loss on disposal of property and equipment

    4,016       80,505  

Stock-based compensation on stock options, RSUs & RSAs, net

    1,261,577       745,155  

Provision for credit losses

    (26,034 )     (3,014 )

Change in operating lease assets and liabilities

    (181,814 )     (91,582 )

Inventory write-offs to allowance

    215,129       135,625  

Deferred taxes

    (64,323 )     (2,368 )

Changes in operating assets and liabilities, net of acquisitions:

               

Trade accounts receivable

    (1,200,965 )     (822,043 )

Other current assets

    (145,353 )     73,362  

Inventories

    (247,597 )     (1,206,340 )

Prepaid expenses and deposits

    (2,182,257 )     (360,439 )

Accounts payable and accrued liabilities

    1,030,382       389,844  

Net cash used in operating activities

    (5,116,579 )     (5,681,447 )
                 

Cash flows from investing activities:

               

Purchase of property and equipment

    (1,844,395 )     (580,726 )

Proceeds from sale of equipment

          10,648  

Acquisition of Amorphous

    (7,000,111 )      

Acquisition of G5

          (20,250,011 )

Net cash used in investing activities

    (8,844,506 )     (20,820,089 )
                 

Cash flows from financing activities:

               

Proceeds from exercise of stock options

    12,503       3,175  

Proceeds from sale of common stock from Employee Stock Purchase Plan

    24,862       14,385  

Proceeds from issuance of common stock under public equity placement, net of fees

    65,242,541        

Proceeds from issuance of common stock under private equity placement, net of fees

    7,894,045       437,725  

Proceeds from issuance of preferred stock under private equity placement, net of fees

          18,842,138  

Proceeds from issuance of warrants under private equity placement, net of fees

          4,620,561  

Earnout payment for acquisition of G5, net of operating portion

    (3,536,471 )      

Deferred payment for acquisition of Visimid

          (125,000 )

Borrowings on loans payable

          6,659,596  

Loan issuance costs

          (597,465 )

Payments on loans payable

    (5,442,930 )     (149,118 )

Repayment of finance lease obligations

    (168,089 )     (133,711 )

Net cash provided by financing activities

    64,026,461       29,572,286  

Effect of exchange rate on cash and cash equivalents

    292,769       (72,133 )

Change in cash and cash equivalents

    50,358,145       2,998,617  

Cash and cash equivalents, beginning of period

    4,877,036       3,480,268  

Cash and cash equivalents, end of period

  $ 55,235,181     $ 6,478,885  
                 

Supplemental disclosure of cash flow information:

               

Interest paid in cash

  $ 390,457     $ 66,136  

Income taxes paid

  $ 194,527     $ 118,016  

Supplemental disclosure of non-cash investing & financing activities:

               

Purchase of equipment through finance lease arrangements

  $ 275,471     $ 93,048  

Operating right-of-use assets acquired in exchange for operating lease liabilities

  $ 1,956,911     $  

Issuance of common stock for acquisition of Visimid

  $ 350,000     $ 713,946  

Issuance of common stock for acquisition of G5, including earnouts

  $ 3,149,942     $ 4,872,068  

Issuance of common stock for acquisition of AML, including earnouts

  $ 1,027,080     $  

Accrual of earnout consideration for acquisition of G5

  $     $ 3,536,471  

Accrual of earnout consideration for acquisition of AML

  $ 1,780,000     $  

Extinguishment of debt in exchange for common stock, preferred stock, warrants and a note

  $     $ 3,057,110